https://www.selleckchem.com/products/ABT-888.html
Melanotic neuroectodermal tumor of infancy (MNTI) is a rare tumor originated from neural crest cells with the potential for recurrence and metastasis. The peak age for the disease is during the first year after birth. The current therapy is primarily surgery. The patient reported here is the first case of MNTI treated with metformin. A case of a 4-month-old infant with a history of swelling in the mouth for 1 month. The tumor was diagnosed using radiology, pathology, and immunohistochemistry, and it was performed with complete surgical
Beğen
Yorum Yap
Paylaş
